Oncology > Novel AntiCancer Agents For Practicing Physicians - New York

Novel AntiCancer Agents For Practicing Physicians

Agenda

Introduction and Opening Remarks	Anthony Tolcher, MD
What Are the New Agents and How Do They Work?	Chris Takimoto, MD, PhD
What Are the New Agents on the Horizon?	Anthony Tolcher, MD
Questions/Discussion
New Agents in Colorectal Cancer for the Practicing Oncologist	Daniel Haller, MD
Questions/Discussion
Novel Agents in Lung Cancer for the Practicing Oncologist	Chandra P. Belani, MD
Questions/Discussion
Break
New Agents in Kidney Cancer for the Practicing Oncologist	Gary Hudes, MD
Questions/Discussion
New Agents in Breast Cancer for the Practicing Oncologist: Consensus and Controversies	Mark Pegram, MD
Questions/Discussion
New Treatment Options for Sarcoma and GIST	Margaret von Mehren, MD
Questions/Discussion
Lunch
New Agents in Hematological Malignancies	Michael Keating, MD
Questions/Discussion
Novel Agents in Ovarian Cancer for the Practicing Oncologist	William McGuire, MD
Questions/Discussion
Individualized Therapies--Pharmacogenomics	Howard McLeod, MD
Questions/Discussion
Brain Tumors: Incorporation of Novel Agent and Combinations	TBD
Questions/Discussion
New Approaches in Supportive Care for the Practicing Physician	Harry Raftopoulos, MD
Questions/Discussion
Closing Remarks and Adjourn	Anthony Tolcher, MD